Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Sabine Behrens

15PUBLICATIONS
207CO-AUTHORS
Gene expression (incl. microarray and other genome-wide approaches)Epidemiological methodsEpigenetics (incl. genome methylation and epigenomics)Multiphysics flows (incl. multiphase and reacting flows)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

Sort by Publication Date:
|Nov 13, 2025
Threshold-Based Overlap of Breast Cancer High-Risk Classification Using Family History, Polygenic Risk Scores, and Traditional Risk Models in 180,398 Women.

Peh Joo Ho, Christine Kim Yan Loo, Ryan Jak Yang Lim

|Jun 25, 2024
The healthy participant effect: insights and results from a population-based case-control study on breast cancer.

Kevin Maldonado-Cañón, Annika Möhl, Nadia Obi

|Sep 26, 2023
Author Correction: Exome sequencing identifies breast cancer susceptibility genes and defines the contribution of coding variants to breast cancer risk.

Naomi Wilcox, Martine Dumont, Anna González-Neira

|Aug 17, 2023
Exome sequencing identifies breast cancer susceptibility genes and defines the contribution of coding variants to breast cancer risk.

Naomi Wilcox, Martine Dumont, Anna González-Neira

|Jul 14, 2023
Spectrum and Frequency of Germline <i>FANCM</i> Protein-Truncating Variants in 44,803 European Female Breast Cancer Cases.

Gisella Figlioli, Amandine Billaud, Qin Wang

|Jun 24, 2023
Endogenous estrogen receptor modulating oxysterols and breast cancer prognosis: Results from the MARIE patient cohort.

Nina Sophia Decker, Theron Johnson, Sabine Behrens

Pageof 3

Frequent Collaborators

10 joint publications

Paul D P Pharoah

7 joint publications

Marjanka K Schmidt

6 joint publications

Heiko Becher

6 joint publications

Thilo Dörk

6 joint publications

Kyriaki Michailidou

6 joint publications

Jenny Chang-Claude

6 joint publications

Douglas F Easton

6 joint publications

Anna Jakubowska

5 joint publications

Irene L Andrulis

5 joint publications

William G Newman

Frequent Collaborators

10 joint publications

Paul D P Pharoah

7 joint publications

Marjanka K Schmidt

6 joint publications

Heiko Becher

6 joint publications

Thilo Dörk

Top Related Videos

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on : Oct 23, 2020

10.7K
Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis
06:03

Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis

Published on : Feb 06, 2020

6.6K
Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay (EMSA) and DNA-affinity Precipitation Assay (DAPA)
11:35

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay (EMSA) and DNA-affinity Precipitation Assay (DAPA)

Published on : Aug 21, 2016

13.0K
See more related videos

Top Related Videos

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on : Oct 23, 2020

10.7K
Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis
06:03

Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis

Published on : Feb 06, 2020

6.6K
Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay (EMSA) and DNA-affinity Precipitation Assay (DAPA)
11:35

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay (EMSA) and DNA-affinity Precipitation Assay (DAPA)

Published on : Aug 21, 2016

13.0K
See more related videos